Guardant Health stock has had several attempts at breaking out of a cup base. The company has a blood test to detect colon ...

Researchers from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified markers of two critical stem ...

Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the strength ...

An international team of researchers has uncovered a promising new avenue for treating colorectal cancer, the world's third ...

Thousands in KY go unscreened for colon cancer because they lack access or don't want colonoscopies or stool-based tests, but there's another option.

Cancer rates in young people are growing, and those in the GI tract are rising fastest of all. Here are five things to know about colorectal cancer from an expert.

For years, doctors told cancer patients to rest. Chemotherapy drained the body and surgery took its toll. Exercise, at best, ...

Takeda (TSE:4502/NYSE:TAK) today announced that it has entered into a license and collaboration agreement with Innovent ...

Currently, organoids and spheroids market growth is fueled by regulatory support for non-animal models and heavy investment ...

A recurrence risk of less than 0.5% at 6 years after surgery may provide a practical definition of “cure” in the setting of colon cancer.

Pfizer Inc. (NYSE: PFE) today announced updated follow-up results from the single-arm Phase 2 PHAROS trial evaluating ...

The horror sequel “Black Phone 2” topped the North American box office charts this weekend with $26.5 million in ticket sales ...